Trials / Terminated
TerminatedNCT00514813
Dynepo Long-Term Safety Study
An Open-Label, Phase IV, Multi-Centre Study to Investigate the Long-Term Safety and Efficacy of Subcutaneous Dynepo in Adult Patients With Anaemia Associated With Chronic Kidney Disease
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 152 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the incidence rate of Treatment Emergent Adverse Events (TEAEs) over 2 years in patients treated with Dynepo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dynepo | Subcutaneous injection either BIW, QW, Q2W or Q4W based on what is appropriate for the subject |
Timeline
- Start date
- 2007-06-06
- Primary completion
- 2008-07-31
- Completion
- 2008-07-31
- First posted
- 2007-08-10
- Last updated
- 2021-07-13
- Results posted
- 2009-11-09
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00514813. Inclusion in this directory is not an endorsement.